News & Trends

Thursday, November 29, 2018

FDA Approves New Acne Treatment

Tuesday, October 30, 2018

Which Cancers Are Linked to Pruritus?

Pruritus is associated with several cancers, including skin cancers, according to the findings of a recent study.

Tuesday, August 28, 2018
The FDA has approved the glycopyrronium (Qbrexza) cloth for the treatment of primary axillary hyperhidrosis and more.
Wednesday, August 3, 2016
This app can help patients with psoriasis better manage their skin disease with features to track symptoms and identify possible triggers. The app also offers the ability to create a picture gallery to track skin progress.
Saturday, July 30, 2016
In a retrospective study of dermatology research awards from the National Institutes of Health (NIH) from 2009 to 2014, researchers found a significant decline in women investigators and a striking reduction in MD-only investigator funding dollars.
Monday, April 25, 2016
Dermatologists from around the world gathered in Washington, DC,  for the 74th Annual Meeting of the American Academy of Dermatology (AAD) to learn about the latest news and research in the field.
Monday, April 25, 2016
Valeant Dermatology has launched its Aspire Higher Scholarship Program that will award scholarships of up to $10,000 each to 9 students who will be attending an undergraduate or graduate education program during the 2016- 2017 school year.
Monday, March 21, 2016
The American  Academy of Dermatology published the much-anticipated new guidelines for diagnosing and treating acne in adolescent and adult patients.
Tuesday, November 17, 2015
The FDA approved the Biologics License Application for Imlygic (talimogene laherparepvec, Amgen), a genetically modified oncolytic viral therapy indicated for the local treatment of unresectable cutaneous, subcutaneous and nodal lesions in patients with melanoma recurrent after initial surgery.